-
September 1, 2023 Big Pharma Steps Onto the Psychedelics WagonThe world of medicine is constantly evolving as more and more research is conducted and...
-
December 22, 2022 Discussing Mindset Pharma’s 2022 Milestones and Future Plans with James LanthierIn this conversation, David and James discuss the great deal of work that Mindset has...
-
June 17, 2022 Psychedelic Business Spotlight – June 17This week in psychedelic business news: ARK Invest advances deep dive into psychedelic stocks; Cybin...
-
April 22, 2022 Psychedelic Business Spotlight – April 22This week in psychedelic business news: Mindset Pharma files a new patent; Ehave's MetaHealthU app...
-
February 4, 2022 Psychedelic Business Spotlight – February 4Levitee Labs Announces Interim CEO and Board of Directors ShuffleThis week in psychedelic business news,...
-
January 31, 2022 Why Mindset Pharma’s Deal with Big Pharma Is a Big Deal for PsychedelicsThe partnership with global pharmaceutical company Otsuka positions the psychedelic medicine company as a leader...
-
January 28, 2022 Psychedelic Business Spotlight — January 28This week in psychedelic business news: A major player begins manufacturing; another rebrands; and one...
-
January 7, 2022 Interview with James Lanthier, CEO of Mindset PharmaCEO of Mindset Pharma, James Lanthier, gives us an overview of his company and the...
-
January 7, 2022 Psychedelic Business Spotlight — January 7This week in psychedelic business news: Mindset Pharma partners with global pharmaceutical company; Awakn Life...
-
January 5, 2022 Mindset Pharma Teams Up with The McQuade Center to Develop 2 Families of Novel Psychedelic CompoundsIt’s yet another sign that the pharmaceutical industry at large is taking the potential of...
